Evoke Pharma, Inc. (EVOK)
NASDAQ: EVOK · IEX Real-Time Price · USD
1.66
-0.09 (-5.14%)
At close:
May 31, 2023, 2:24 PM
1.67
+0.01 (0.60%)
After-hours:
May 31, 2023, 4:45 PM EDT
Evoke Pharma Stock Forecast
Stock Price Forecast
There is currently no analyst price target forecast available for Evoke Pharma.
Analyst Consensus: n/a
Analyst Ratings
There are currently no analyst ratings available for Evoke Pharma.
Recommendation Trends
| Rating | Jan '20 | Feb '20 | Mar '20 | Apr '20 | May '20 | Jun '20 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 | 1 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 1 | 1 | 0 |
Financial Forecast
Revenue This Year
5.05M
from 2.51M
Increased by
101.22%
Revenue Next Year
10.49M
from 5.05M
Increased by
107.71%
EPS This Year
-2.20
from -2.62
EPS Next Year
-1.26
from -2.20
| Year | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Revenue | - | - | 23.02K | 1.62M | 2.51M | 5.05M | 10.49M |
| Revenue Growth | - | - | - | 6,929.00% | 55.04% | 101.22% | 107.71% |
| EPS | -5.52 | -3.84 | -6.24 | -3.18 | -2.62 | -2.20 | -1.26 |
| EPS Growth | - | - | - | - | - | - | - |
| No. Analysts | - | - | - | - | - | 3 | 3 |
Revenue Forecast
| Revenue | 2023 | 2024 |
|---|---|---|
| High | 5.2M | 10.8M |
| Avg | 5.0M | 10.5M |
| Low | 4.9M | 10.1M |
Revenue Growth
| Revenue Growth | 2023 | 2024 |
|---|---|---|
| High | 107.1%
| 113.8%
|
| Avg | 101.2%
| 107.7%
|
| Low | 93.3%
| 99.5%
|
EPS Forecast
| EPS | 2023 | 2024 |
|---|---|---|
| High | -2.27 | -1.30 |
| Avg | -2.20 | -1.26 |
| Low | -2.12 | -1.22 |
EPS Growth
| EPS Growth | 2023 | 2024 |
|---|---|---|
| High | - | - |
| Avg | - | - |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.